The Chronic Lymphocytic Leukemia v3 Panel (CLLv3), also known as SOPHiA DDM™️ Community CLL Clonality Solution, covers 23 genes commonly associated with this pathology. Additionally, this panel includes the study of immunoglobulin rearrangements, enabling the determination of the somatic hypermutation status (SHM) of the Immunoglobulin heavy chain (IGHV) and the presence of the R110 mutation in the IGLV3-21 rearrangement.
The kit is based on NGS technology by capture and includes all the necessary reagents for the preparation of libraries compatible with Illumina platforms. Variant interpretation is performed on the SOPHiA DDM platform, designed for the analysis and secure management of clinical NGS data in routine diagnostics.
The analysis of Immunoglobulin rearrangements is conducted using the IgCallerWeb platform, a simple and intuitive web application developed by the August Pi i Sunyer Biomedical Research Institute (IDIBAPS).
This solution allows for the comprehensive analysis of key prognostic and predictive markers in CLL in a single workflow, including those outlined in international guidelines.
